Company intelligence / Profile preview

Xilis

Durham, North Carolina, United Statesxilis.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Xilis has developed the MicroOrganoSphere™ technology—a next-generation patient-derived microtumor model that allows rapid functional drug response testing using biopsies from individual patients. This enables clinicians to make timely precision treatment decisions in oncology and supports high-throughput drug discovery for pharmaceutical partners. The company’s approach aims to transform personalized cancer care by providing scalable, clinically relevant tumor models.

Therapeutic areas: Oncology
Modalities: Patient-derived microtumors (MicroOrganoSphere™ technology)Functional tumor models for drug testingNot directly developing small molecules or biologics; platform enables testing of various modalities
Industry: Drug Discovery Services

Partnerships

Pharmaceutical companies engaged in drug discovery collaborations using MOS technology; specific names not disclosed but described as "world-leading pharmaceutical partners."

Beyond the preview

Go deeper on Xilis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xilis.

Explore the full profile